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SUMMARY
The capacity of various leucoattractants to enhance, or unfold, receptors for complement (C3b)
on human blood monocytes has been studied. A number of recognized monocyte chemoattrac-
tants including casein, supernatants from C. parvum 10390 and from human lymphocytes (cul-
tured either in the presence or absence of phytohaemagglutinin) and the formyl-methionyl
peptides, F-Met-Leu-Phe, F-Met-Met-Phe and F-Met-Phe, increased the percentage of mono-
cytes which formed rosettes with IgM-sensitized sheep erythrocytes coated with complement.
Comparable results were achieved irrespective of whether purified components or whole serum
was used as a source of complement. In contrast, there was no significant increase in EAG (Fc)
rosettes with those doses of casein which gave enhancement of C3b receptors. A small degree of
complement receptor enhancement was observed with histamine but the unformylated peptides,
Met-Leu-Phe and Met-Met-Phe, were without apparent effect. Maximal receptor enhancement
was obtained at 30 min but when the leucoattractant was removed, enhancement was reversible,
returning to normal values in approximately 120 min. Monocyte complement receptor enhance-
ment increased with temperatures between 0C and 370C.
These data (1) confirm and extend our previous findings on leucoattractant-induced enhance-
ment of complement receptors on human monocytes; (2) indicate that the phenomenon may have
potential as a clinical test for monocyte function both in health and disease.
INTRODUCTION
We recently reported that complement receptors on human eosinophils were enhanced, or unfolded,
following incubation with various pharmacological mediators to which they migrate in chemotaxis and/or
chemokinesis. A number of eosinophilotactic agents, including the eosinophil chemotactic factor of
anaphylaxis (ECF-A) tetrapeptides (Val-Gly-Ser-Glu and Ala-Gly-Ser-Glu), histamine and one of its
major catabolites, imidazoleacetic acid, selectively enhanced receptors for complement (C3b and C4) on
human eosinophils in a dose- and time-dependent fashion (Anwar & Kay, 1977a; Anwar & Kay, 1978).
Later, in a short report we established that human neutrophils and monocytes undergo a similar enhance-
ment of complement receptors following incubation with substances to which they are known to migrate
in vitro (Kay, Glass & Salter, 1979). This suggested that complement receptor enhancement by leuco-
attractants may be a general biological phenomenon which might provide a mechanism whereby the
degree of adhesion of phagocytic cells to opsonized particles was increased.
For these reasons it seemed important to provide further information on leucoattractant-induced
complement receptor enhancement by various cell types and in the present report the monocyte has been
studied in detail. Thus, we have confirmed and expanded our original observations by studying the
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effect of leucoattractants on both complement and IgG receptors, by undertaking time course experi-
ments over a broad concentration range, examining a number of agents which promote monocyte
migration and determining whether the phenomenon is reversible and temperature-dependent.
MATERIALS AND METHODS
Materials. Materials were obtained as follows. Casein (BDH Chemicals Limited, Poole, Dorset); phytohaemagglutinin
(PHA-P, Wellcome Reagents Limited, Beckenham, Kent); C. parvum 10390 supernatant was a gift from Dr W. McBride
(Department of Bacteriology, Medical School, University of Edinburgh); histamine acid phosphate (BDH Chemicals
Limited, Poole, Dorset); F-Met-Leu-Phe was a gift from Dr Derek Hudson (Royal Postgraduate Medical School London),
F-Met-Met-Phe, Met-Leu-Phe and Met-Met-Phe were gifts from Miles Laboratories (Stoke Poges, England); F-Met-Phe
was obtained from Sigma Chemical Company (St Louis, Missouri, USA); preservative-free heparin (Evans Medical,
Liverpool); Ficoll and Hypaque (Pharmacia, Uppsala, Sweden).
Preparation ofEA, EAC1423b and 'EAC', This has been described elsewhere (Anwar & Kay, 1977b; Anwar & Kay, 1978)
and was briefly as follows. Dextrose-gelatin-veronal buffer (DGVB2+ pH 7.4 was used for washing sheep erythrocytes (E)
during sensitization and coating with complement. The buffer was prepared by mixing equal volumes of isotonic Veronal-
buffered saline (containing 0-0015 M Ca2+ 0-0005 M Mg2+ and 0-1% gelatin-Veronal buffer GVB2+) with 5% dextrose in
water containing the same concentration of Ca2 + and Mg2+. The IgM and IgG fractions of rabbit antisera to sheep red cells
(A) were prepared by Sephadex G-200 gel filtration (Shevach et al., 1972). The IgG fraction was purified further by DEAE-
52 anion exchange chromatography (Fahey & Terry, 1978). Either IgG or IgM was used in the sensitization of E for the
preparations of EAr"b or EAr"b respectively. The antibody concentration of EArb selected was that which gave optimal
sensitization for haemolysis but no agglutination. For the preparation ofEArGb, the antibody concentration was diluted so as
to give approximately 30% monocyte rosettes. Functionally pure human complement components were added sequentially to
EA rab to prepare C3b coated cells (EAC1423b). The amounts were as follows: 400 effective molecules of Cl, 400 of C4, 50
of C2 and 400 of C3. This amount of C4 was insufficient to give EAC14 rosettes with monocytes (Anwar & Kay, 1978). In
some experiments fresh human AB serum was also used as a source of complement ('EAC'). Equal volumes of EA rab at a
concentration of 1 x 108 cells/ml and human AB serum, diluted with DGVB2+, were mixed and resuspended in the same
buffer to give a final concentration of 1 x 108 red blood cells/ml. The dilution of fresh serum was adjusted to give between
20 and 30% monocyte rosettes and was usually between 1 in 600 and 1 in 1000.
Monocytes. Blood from healthy donors was drawn into plastic tubes containing 10 units of preservative-free heparin/ml.
Monocytes were separated on Ficoll-Hypaque cushions according to the method ofBoyum (1968). The separated cells were
washed twice in Dulbecco's PBS (modified) (pH 7 2-7.4), containing preservative-free heparin (2 units/ml) and resuspended
in medium 199, pH 7 4, to a concentration of 1 x 102 monocytes/ml.
Lymphocyte supernatants. A cell suspension containing up to 90% lymphocytes was obtained using defibrinated blood as
described by Boyum (1976). The separated cells were resuspended to a concentration of 3 x 106 lymphocytes/ml in medium
199. Under sterile conditions, and with added penicillin and streptomycin, 9 pI of PHA-P (0.5) ,ug/ml) were added to 3 ml
of the mononuclear cell suspension. The cells were incubated for 3 days at 37°C in a humidified atmosphere containing 5%
CO2. After incubation the supernatants were harvested by centrifugation, aliquoted and stored at - 70°C until use. The
unstimulated lymphocyte supernatants were prepared in an identical fashion with the exception that PHA-P was added at
the end of the 3-day incubation period.
Complement (EAC) and IgG (EAG) rosettes. Equal volumes of monocytes (1 x 106/ml) and various concentrations of the
leucoattractants under study or medium alone as a control, were mixed and incubated in a shaking water bath usually at
37°C for 30 min. The cells were then washed twice in medium 199 and the numbers readjusted to their original concentration
in the same medium. A portion (0 1 ml) ofEAC or EAG (1 x 108/ml) was added to 0 1 ml for 10 min at 4°C and the pellets
incubated at 37°C for 20 min for EAC and 0°C for 30 min in the preparation of EAG. The pellet was resuspended gently in
medium 199 containing 1% formal-saline and smears prepared on clean glass slides in duplicate. These were dried quickly in
air, fixed in methanol and stained with May-Grunwald/Giemsa or fixed in 2.5% glutaraldehyde and stained using LX-naphthyl
acetate histochemistry according to the method ofYam, Li & Crosby (1971). Comparison of these two methods by four inde-
pendent observers revealed no statistical significance in differentiating monocytes from lymphocytes.
RESULTS
Casein enhanced the percentage of monocyte C3b rosettes in a dose-dependent fashion (Fig. 1) irrespec-
tive of whether 'EAC' or EAC1423 were used as indicator cells. In contrast there was a small but
insignificant increase in the percentage ofEAG (Fc) rosettes. With the highest dose of casein the mean
values for enhancement of Fc receptors was 13% whereas with 'EAC' and EAC1423 the increase was
92% and 100% respectively.
Enhancement of complement receptors by casein was also dependent on the time of incubation.
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FIG. 1. The effect of casein on monocyte C3b and IgG rosettes. (0) EAM1423, (a) 'EAC', (1) EAG. Each
column represents the mean± s.e.m. of three experiments. Casein was dissolved in distilled water and the pH
raised to 11 with 1 N NaOH. The pH was then adjusted to 7-4 with 1 N HCI. Nine parts of the casein solution
were then added to one part of 10-times concentrated medium 199 with HEPES buffer, pH 7-4.
Maximal effects were observed at about 30 min after which there was no further increase (Fig. 2).
Similar results were obtained irrespective ofwhether 'EAC' or EAC1423 were used as indicator red cells.
A small but insignificant increase in Fc receptors was also observed in this time course study and was
maximal after approximately 60 min. By 120 min this small increase had returned to the original value.
As the dose-response and time-course studies were essentially similar using either 'EAC' or EC1423,
'EAC' were used as indicator cells in further experiments.
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FIG. 2. The time-course of the percentage enhancement of monocyte rosettes by casein using sensitized
erythrocytes coated with complement or IgG. (0-0) 'EAC', (0-0) EAMC1423, (oku) EAG. Each point
represents the mean+ s.e.m. of three experiments. The casein was prepared as in Fig. 1.
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FIG. 3. The time-course ofmonocyte complement receptor enhancement by increasing concentrations of casein.
(e-e) 3 mg/ml casein, (0-o), 2 mg/ml casein, (d-r*) 1 mg/ml casein. Each point represents the mean
± s.e.m. of three experiments. The indicator red cells were 'EAC' (prepared with whole serum as a source of
complement).
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FIG. 4. The effect of various leucoattractants on the expression of monocyte complement receptors. (*--)
C. parvum 10390, (0-0) 'stimulated', (u-u) 'unstimulated', (0-1E) histamine. Each point represents the
mean+ s.e.m. of three experiments, except for histamine in which four experiments were performed. The C.
parvum 10390 supernatant was prepared from formaldehyde-killed C. parvum organisms which had been washed
twice in 0.9% NaCl, lyophilized and reconstituted in distilled water. The reconstituted material had a
concentration of 7 mg/ml dry weight which represented 3 x 1011 organisms. The indicator red cells were
'EAC' as in Fig. 3.
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FIG. 5. The effect of formyl-methionyl peptides on the expression of monocyte complement receptors. (0-*)
F-Met-Leu-Phe, (0-0) Met-Leu-Phe, (I-u) F-Met-Met-Phe, (E-R) Met-Met-Phe, (A-A) F-Met-Phe.
Each point represents the mean+ s.e.m. of three experiments. The peptides were dissolved in dimethyl
sulphoxide (DMSO) at a concentration of 10-2 mol/l and further diluted in medium 199 to the required
concentrations. At the highest dose used (10's mol/l) the concentration ofDMSO was approximately 10-2
mol/l and at this concentration had no effect on cell viability as determined by trypan blue exclusion and
locomotion in vitro through micropore filters (Kay, Glass & Salter, 1979). The indicator red cells were 'EAC'
as in Fig. 3.
The effect of increasing doses of casein on the rate and degree of enhancement of monocyte comple-
ment receptors is shown in Fig. 3. The degree of enhancement and the rate at which enhancement
occurred was dependent on the concentration of casein. Increasing the concentration of casein from 1
mg/ml to 2 mg/ml increased the rate ofmonocyte rosette enhancement three-fold. Further increase in the
concentration of casein up to 3 mg/ml had no apparent effect on the rate ofcomplement receptor enhance-
ment.
Other recognized monocyte chemoattractants were tested for their capacity to enhance monocyte
complement receptors. Supernatants from lymphocytes stimulated with PHA increased the numbers of
monocyte rosettes in a dose-dependent fashion (Fig. 4). In contrast, unstimulated lymphocyte super-
natants had significantly less effect when tested at comparable dilutions. A leucoattractant elaborated
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FIG. 6. Reversibility of monocyte complement receptor enhancement. Each point represents the mean+ s.e.m.
of three experiments. Monocytes were pre-incubated with 3 mg/ml ofcasein for 30 min at 370C, centrifuged and
the cells resuspended in medium 199 to the original volume and incubated at 370C for various time intervals
as shown. The indicator red cells were 'EAC' as in Fig. 3.
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FIG. 7. The effect of temperature on monocyte complement receptor enhancement. (e *) 3 mg/ml casein,
(0-0) 2 mg/ml casein, (u-u) 1 mg/ml casein, (n-o) medium 199. Each point represents the mean±
s.e.m. of three experiments. The indicator red cells were 'EAC' as in Fig. 3.
from C. parvum 10390 also had a similar effect. Histamine gave a slight increase in the percentage of
monocyte complement rosettes at doses of 10-5 and 10-6 mol/l.
A number of formyl-methionyl peptides were also tested for their effects on monocyte complement
receptors (Fig. 5). With F-Met-Leu-Phe activity was observed at 10' and 10-8 mol/l with little
enhancement at 10' mol/l. F-Met-Met-Phe and F-Met-Phe were less active than F-Met-Leu-Phe
but both gave enhancement at 10' and 10'6 mol/l but not at 10-' mol/l. The unformylated
peptides, Met-Leu-Phe and Met-Met-Phe, were virtually inactive.
Monocyte complement receptor enhancement appeared to be reversible (Fig. 6). Following 30 min
incubation with casein the cells were washed and resuspended in medium 199. There was a gradual
decrease in monocyte rosette enhancement and by 120 min there was no discernible difference from the
controls. The experiments were reported with F-Met-Leu-Phe (l0-' mol/l) and gave virtually iden-
tical results.
Monocyte complement receptor enhancement was also temperature dependent as shown in Fit. 7. At
0C there was no increase in the percentage of rosettes formed with any of the concentrations of casein
used. However, at 23, 30 and 370C, enhancement was observed and increased proportionally with the rise
in temperature. The increase in monocyte complement receptor enhancement was particularly marked
between 30'C and 370C. The higher concentrations of casein gave correspondingly increased rosette
formation at these temperatures.
DISCUSSION
In a recent short report we established that leucoattractants enhance complement receptors on human
neutrophils and monocytes (Kay, Glass & Salter, 1979), and that these observations, taken together with
previous studies on the eosinophil (Anwar & Kay, 1977a; Anwar & Kay, 1978) indicated that comple-
ment receptor enhancement by agents which promote cell locomotion might be a general biological
phenomenon. In the present report we have studied details of complement receptor enhancement on the
blood monocyte. It seemed important to extend our knowledge of complement receptors to human
monocytes since cells of the monocyte/macrophage series are not only specialized phagocytic cells but
also synthesize and secrete a variety of products into their immediate microenvironment. In addition,
quantification of the degree of complement receptor enhancement might provide a further variable for
studies of monocyte function both in health and disease.
The rosette method for identifying cell surface markers is a well established technique. However, a
major disadvantage, which applies particularly to the present study is the difficulty in measuring the
degree of binding between the monocyte membrane and individual indicator erythrocytes. For instance,
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treatment with the various leucoattractants not only increased the percentage of monocytes having three
or more adherent red cells but the red cell binding itself appeared far more 'firm' than that observed in
the untreated controls. Techniques that facilitate measurements of the binding affinity are required to
appreciate the full extent of the complement receptor enhancement phenomenon.
It should be noted that in the present experiments the amount of complement on the red cells was
limited to give approximately 25-35% rosettes in the untreated (control) monocyte suspensions. Even
when the amount of complement was increased or when optimal conditions were used for complement
receptor enhancement, it was unusual to achieve greater than 75% monocyte rosettes. This suggested
that there might be a population of monocytes which express complement receptors poorly. They may
be either immature cells or possibly an as yet unidentified subset.
The capacity of casein to attract human monocytes in directional and random motion is well estab-
lished (Keller & Sorkin, 1967) and, therefore, it seemed reasonable to use this agent in the majority of
experiments. However, a number of other agents with chemotactic activity for monocytes gave compar-
able increases in the percentages of complement rosettes (Figs 4 and 5). These included supernatants
from lymphocytes cultured in the presence of PHA (Snyderman et al., 1972), a supernatant from C.
parvum 10390 (Wilkinson, O'Neill & Wagshaw, 1973) and several formyl-methionyl peptides (Showell
et al., 1976). Snyderman et al. (1972) found a certain amount of monocyte chemotactic activity in super-
natants from unstimulated lymphocytes. In the present study the highest concentration of the unstimu-
lated supernatants also gave enhancement of monocyte complement rosettes. These observations all
support the view that there is a direct relationship between cell locomotion and enhancement of comple-
ment receptors (Kay, Glass & Salter, 1979).
The apparent inability of casein and F-Met-Leu-Phe to alter receptors for IgG on the monocyte is in
agreement with previous observations on the eosinophil in which it was found that chemoattractants
affected the expression of complement but not Fc receptors (Anwar & Kay, 1977a; Anwar & Kay, 1978).
The reasons for these apparent differences between complement and IgG receptors is not clear at this time
but may be explained by the experimental procedure. For instance, optimal IgG rosettes are obtained at
00C whereas 370C is used for complement. Also, in the time course experiment (Fig. 2) a slight increase
in Fc receptors was found but this was statistically insignificant. Although it seems likely that IgG
receptors are not enhanced to the same degree as complement receptors, further studies using different
techniques for studying cell surface markers (i.e. immunofluorescence) will be required before firm
conclusions can be drawn.
We have considered the possibility that our observations might have been the result of unfolding of
receptors forIgM (Fc), rather than for complement, in a similar way that Vibrio cholerae neuraminidase
exposes cryptic sites for the Fc portion ofIgM on rabbit and human monocytes (Haegert, 1979). It is
unlikely that our present findings can be explained in this way since, at least with human neutrophils and
eosinophils, receptor enhancement was observed with EAMC1423b and EAMC14 but not with
EAMC1423b' (i.e. C3b cells treated with the C3b inactivator (Law, Fearon & Levine, 1979)). Thus not all
complement intermediates prepared with EAM react in receptor enhancement (Anwar & Kay, 1978).
Comparable experiments with monocytes using red cells coated with various complement components
are in progress as are blocking studies withIgM.
Although we have drawn the general conclusion that agents which promote cell locomotion also
enhance complement receptors, we cannot say with certainty whether this effect is related to their
chemotactic and/or chemokinetic principles. It has been shown that casein (Keller & Sorkin, 1967), the
F-Met peptides (Showell et al., 1976) and C. parvum chemotactic factor (Russell et al., 1976) promote
directional migration as well as increasing the rate of cell movement. In order to establish that the
chemotactic, rather than the chemokinetic, principle is required for complement receptor enhancement,
further studies using substances which increase random migration, but are not chemotactic, are required.
As discussed elsewhere (Anwar & Kay, 1978) possible explanations of the mechanisms of complement
receptor enhancement include 'membrane unfolding', 'receptor externalization' and 'subunit association'.
The generation of new receptors was considered unlikely since optimal enhancement, at least with casein,
was achieved by 30 to 60 min.
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Complement receptor enhancement on the monocyte (and also the neutrophil (E. J. Glass, unpub-
lished observation)) appears to be both reversible (Fig. 6) and temperature-dependent (Fig. 7). Although
these findings do not support any single mechanism (see above) they may be useful observations in our
endeavours to provide insight into the mechanism ofcomplement receptor enhancement. For instance, it
is reasonable to suppose that during receptor enhancement there is an alteration in membrane fluidity
which is both reversible (Fig. 6) and probably occurs in the upper temperature range, i.e. between 30'C
and 370C (Fig. 7). By the use of a combination of various techniques which might include cell membrane
fractionation, the use of radiolabelled complement components and membrane fluidity probes we hope
to develop further our knowledge of this phenomenon.
At the present time one of our principal interests relates to the possibility of complement receptor
enhancement as a useful clinical laboratory test. For instance, although the response to histamine is
usually small there is a marked enhancement of monocyte complement receptors by this agent in a few
individuals (E. J. Glass, unpublished observation). The reasons for such variations between apparently
healthy individuals are presently unclear but the possibility that it may be related to their atopic state is
being explored. Also, the effect of tumour-derived products on complement receptor enhancement by
normal monocytes is the subject of study in progress (Glass & Kay, 1979), details of which will be the
subject of a separate report.
This work was supported by the Cancer Research Campaign.
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